Baidu
map

2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症

2021-12-16 英国国家卫生与临床优化研究所 NICE官网

关于利司扑兰 (Evrysdi) 治疗成人和 2 个月及以上儿童 5q 脊髓性肌萎缩症 (SMA) 的循证建议。

中文标题:

2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症

英文标题:

Risdiplam for treating spinal muscular atrophy

发布日期:

2021-12-16

简要介绍:

关于利司扑兰 (Evrysdi) 治疗成人和 2 个月及以上儿童 5q 脊髓性肌萎缩症 (SMA) 的循证建议

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症.pdf)] GetToolGuiderByIdResponse(projectId=1, id=555651c0023020e3, title=2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症, enTitle=Risdiplam for treating spinal muscular atrophy, guiderFrom=NICE官网, authorId=0, author=, summary=关于利司扑兰 (Evrysdi) 治疗成人和 2 个月及以上儿童 5q 脊髓性肌萎缩症 (SMA) 的循证建议。, cover=https://img.medsci.cn/20211227/1640572465085_1608702.png, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Thu Dec 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #0e0e0e;">关于利司扑兰 (Evrysdi) 治疗成人和 2 个月及以上儿童 5q 脊髓性肌萎缩症 (SMA) 的</span><span>循证建议</span><span style="color: #0e0e0e;">。</span></p>, tagList=[TagDto(tagId=20393, tagName=脊髓性肌萎缩症), TagDto(tagId=61647, tagName=神经重症)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=20393, guiderKeyword=脊髓性肌萎缩症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2227, appHits=44, showAppHits=0, pcHits=442, showPcHits=2181, likes=0, shares=1, comments=4, approvalStatus=1, publishedTime=Sat Dec 25 22:04:17 CST 2021, publishedTimeString=2021-12-16, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sat Dec 25 22:14:28 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 20:16:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症.pdf)])
2021 NICE 指南:利司扑兰治疗脊髓性肌萎缩症.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184718, encodeId=07401184e1811, content=很好的循证建议, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:56:30 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084626, encodeId=eb89108462658, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec595703309, createdName=ms3000000094650317, createdTime=Mon Dec 27 11:14:31 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-01-15 1e22b426m70(暂无匿称)

    很好的循证建议

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184718, encodeId=07401184e1811, content=很好的循证建议, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:56:30 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084626, encodeId=eb89108462658, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec595703309, createdName=ms3000000094650317, createdTime=Mon Dec 27 11:14:31 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 ms3000000094650317

    学习

    0

拓展阅读

脊髓性肌萎缩症多学科管理专家共识

中国神经内科相关专家小组(统称) · 2019-05-21

脊髓性肌萎缩症呼吸管理专家共识(2022版)

中国医师协会儿科医师分会 · 2022-03-25

青少年成人脊髓性肌萎缩症临床诊疗指南

中国研究型医院学会罕见病分会 · 2023-01-30

脊髓性肌萎缩症临床实践指南

脊髓性肌萎缩症临床实践指南工作组 · 2023-02-25

2023 NICE 高度专业化的技术指南:用于治疗症状前脊髓性肌萎缩症的 Onasemnogene abeparvovec【HST24】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-04-19

Baidu
map
Baidu
map
Baidu
map